PTPA and epilepsy: Therefore, these findings indicate that PDI may regulate surface AMPAR expression via PP2A-mediated GluA2 S880 dephosphorylation, and suggest that PDI may be one of the therapeutic targets for epilepsy via AMPAR internalization without altering basal neurotransmission.